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Abstract
Spinel Ni0.3Zn0.7Fe2O4 (NZFO) magnetic nanoparticles was prepared by the low temperature auto-combustion method
using a glycine fuel-rich composition without any further heat treatment at high temperature. Subsequently, the synthesized
MNPs were coated with Pluronic P123 (PP123) after its surface was functionalized with oleic acid (OA). The effect of the
coatings on the morphology, structural and magnetic properties of NZFO nanoparticles was studied using powder X-ray
diffraction (XRD), Fourier transform infrared, thermogravimetric analysis, field emission scanning electron microscopy
(FE-SEM) and vibrating sample magnetometer (VSM). The colloidal behaviour of coated MNPs in physiological saline
medium like water or phosphate buffer saline (PBS) was also studied by zeta potential measurements. XRD results showed
the formation of cubic spinel crystalline phase with and without OA–PP123 coatings. Also, after OA–PP123 coating, the
crystallite size (from Scherrer formula) decreases from 55 to 53 nm. However, an enlargement in the particle size and a
reduction in agglomeration were observed from FE-SEM results when the nanoparticles were coated with OA–PP123.
VSM measurements showed ferromagnetic behaviour at room temperature before and after coating. The colloidal stability
study of the coated sample revealed a considerable high zeta potential value at physiological pH (7.4) highlighting its
potential biomedical applications.
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1 Introduction
The biomedical applications of magnetic nanoparticles
(MNPs) mostly in hyperthermia and targeted drug delivery
have been extensively studied in the last two decades.
Among nanomaterials used in biomedical applications,
MNPs are particularly attractive because they have inher-
ent magnetic properties. Thus, they can be remotely
manipulated by an external magnetic field thereby serving
as vectors for drug targeting (Banerjee and Chen 2007;
Rahimi et al. 2010) or local heat sources in hyperthermia-
based therapy (Jordan et al. 1999; Baldi et al. 2009). Fur-
thermore, MNPs can be designed to combine therapeutic
(hyperthermia and drug delivery) modalities to generate a
synergistic effect for cancer treatment—the so-called
multifunctional nanoparticles (Kulshrestha et al. 2012;
Shah et al. 2012).
The spinel ferrites—ferro(i)magnetic or superparamag-
netic nanomaterials, with general formula MFe2O4
(M = Mn, Fe, Ni, Co, Zn, Mg) which are stable and have
appreciable magnetizations have been well investigated in
biomedical applications. In this regard, superparamagnetic
iron oxide nanoparticles (SPIONs) have been the most
appealing because of their biocompatibility, low toxicity,
ease of synthesis, enhanced specific loss power and easy
functionalisation. However, there has been no consensus on
the choice of the type of MNPs most suitable for
biomedical applications as many studies (Kashevsky et al.
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2015; Uskokovic et al. 2006; Maier-Hauff et al. 2011;
Sakellari et al. 2016) have revealed the advantages of
employing ferro(i)magnetic materials over superparamag-
netic materials. Also, in spite of the numerous advantages
of SPIONs, it is not possible to control the temperature
distribution hence MNPs with tunable Curie temperature
(Tc) are intensively investigated. Syntheses of several
materials such as La1-xSrxMnO3 and M1-xZnxFe2O4 (with
M = Ni, Cu, Co, Mn) with adjustable Tc have been
reported (Kuznetsov et al. 2002; Apostolov et al. 2013;
Nguyen and Kyo-Seon 2014). NiFe2O4 is one of the most
important spinel magnetic ceramics which finds interests in
biomedical applications due to its low cost, excellent
chemical stability, high electromagnetic performance and
moderate saturation magnetization. Zn2? ions, a non-
magnetic substituent, have been used to reduce the Tc in
spinel ferrites (Morrison et al. 2004; Gul et al. 2008).
Among the series of Ni1-xZnxFe2O4 compounds, the
Ni0.3Zn0.7Fe2O4 (NZFO) has been calculated to have a Tc
of * 310–315 K which is suitable for biomedical appli-
cations like magnetic hyperthermia.
A major requirement for the biomedical applications of
MNPs is the coating of their surfaces with a given bio-
compatible and functional layer. MNPs should be func-
tionalized by organic or inorganic materials such as silica,
polymers and other surfactants to achieve better physical
and chemical properties. For example, this should lead to
enhanced stable colloidal solutions and biocompatibility to
prevent endocytosis by macrophages as well as to extend
their residence time in blood circulation (Nguyen and Kyo-
Seon 2014). The surface coatings can also provide func-
tional surfaces for further modifications like in targeted
drug delivery of anti-cancer chemotherapeutic agents.
Mamani et al. (2013) has reported less agglomerated lauric
acid-coated MNPs which can be used for biomedical
applications. Dutz et al. (2007) showed that dextran coating
of iron oxide nanoparticles not only influenced the mag-
netic behaviour of the nanoparticles but reduced signifi-
cantly the agglomeration of the nanoparticles thereby
making them very suitable for combined hyperthermia and
chemotherapeutical applications. Dorniani et al. (2014)
reported improvement in the thermal stability of both
polyethylene glycol–gallic acid and polyvinyl alcohol–
gallic acid coated SPIONs compared to their uncoated
counterparts. Polyvinyl alcohol coatings on Ni0.3Zn0.7Fe2-
O4 nanoparticles were found to increase the relative sen-
sibilities of the samples to the variation of applied
frequency (enhancing their hyperthermia-based therapy
applications) compared to the uncoated samples (Rahimi
et al. 2013).
In the present study, an attempt has been made to pre-
pare NZFO MNPs using a glycine-mediated low temper-
ature combustion method and subsequently coated these
nanoparticles with oleic acid (OA) and then stabilised with
a block copolymer Pluronic P123 (PP123). Similar type of
formulations has been extensively studied for iron oxide
MNPs (Morales et al. 2005; Gonzales and Krishnan 2007)
and lanthanum strontium manganite MNPs (Thorat et al.
2014) for biomedical applications. Since the coating of
polymers on the surface of MNPs can alter some important
properties of the particles, the effect of PP123–OA coatings
on the structural, morphological and magnetic properties is
discussed in detail. The colloidal stability of bare and
PP123-coated NZFO MNPs in water was examined. The
colloidal stability of PP123-coated NZFO MNPs in phos-
phate buffer solution (PBS) at pH 7.4 (physiological pH)
and pH 5.0 (cancer cell endosomal pH) was also studied to
highlight its stability in different physiological media.
2 Experimental
2.1 Materials
Nickel nitrate [Ni(NO3)26H2O], zinc nitrate [Zn(NO3)2-
6H2O], and iron nitrate [Fe(NO3)39H2O] obtained from
Sigma Aldrich, Germany are taken as oxidants while gly-
cine (C2H5NO2) obtained from SD Fine Chem. Ltd.,
Mumbai was employed as fuel to drive the combustion
process. Triblock co-polymer PP123 (M.W. * 5800) and
oleic acid (OA) are Sigma-Aldrich, Germany products. All
the reagents are of analytical grade and are used as-re-
ceived without further purification.
2.2 Synthesis of NZFO MNPs
The spinel NZFO MNPs were prepared by the low tem-
perature auto-combustion method using a glycine fuel-rich
composition without any further heat treatment at high
temperature. The advantage of combustion synthesis with
glycine in a fuel-rich composition has been studied in our
recent publication (Ehi-Eromosele et al. 2015). Stoichio-
metric amounts of Ni(NO3)6H2O, Zn(NO3)26H2O,
Fe(NO3)39H2O and over-stoichiometric amounts of
C2H5NO2 were dissolved in 20 mL of de-ionised water.
Then the solutions were heated to 80 C to form a viscous
gel of precursors under magnetic stirring. Second, the gel
was transferred to a pre-heated coil (300 C). Finally, after
a short moment, the solution precursors boiled, swelled,
evolved a large amount of gases and ignited, followed by
the yielding of puffy black products. The powder (auto-
combustion powder) was heated in a hot air oven at 200 C
for about 12 h to remove any organic product or unreacted
glycine.
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2.3 Synthesis of Surface-Coated NZFO MNPs
The synthesis of the surface-coated NZFO MNPs was
carried out using the procedures reported by Thorat et al.
(2014) but with slight modifications. First, to achieve the
OA coating of NZFO MNPs, the NZFO MNPs (100 mg)
were dispersed in methanol (100 mL) by sonication for
20 min. During the sonication, oleic acid (10 mL) was
added into the solution. The solution was then heated at
75 C with vigorous stirring for the complete removal of
methanol by evaporation and then cooled to room tem-
perature. The solution was washed three times with acetone
and filtered. The filtered particles were redispersed in
acetone to remove excess oleic acid and the final particles
(NZFO–OA) were collected. In the second step, the coating
of PP123 on OA-coated NZFO MNPs was done. 20%
(corresponding to total weight of NZFO–OA MNPs) PP123
was dispersed in 100 mL distilled water at 60 C with
stirring. 100 mg NZFO–OA was added to the solution and
ultrasonicated for 30 min for well dispersion of OA-coated
MNPs. The solution was stirred in a closed container for
48 h. After stirring, the particles were separated by ultra-
centrifugation at 10,000 rpm for 20 min, with the super-
natant discarded and the sediment washed with distilled
water thrice and then dried at 60 C for 1 h. The prepared
sample (OA–PP123–NZFO MNPs) is used for further
characterisations.
2.4 Physico-Chemical Characterisation
The X-ray diffractograms of the bare and coated (OA–
PP123–NZFO) MNPs were recorded using an X-ray
diffractometer (D8 Advance, Bruker, Germany), equipped
with a Cu Ka radiation source (k = 1.5406 A˚) and the
crystallite size was calculated by the well-known Debye–
Scherrer relation:
D ¼ 0:9k
b cos h
ð1Þ
where b is the full-width at half maxima (in radians) of the
strongest intensity diffraction peak (311), k is the wave-
length of the radiation and h is the angle of the strongest
characteristic peak. Equation 2 was employed to calculate
the lattice parameter (a) using the value of d-spacing of the
strongest intensity diffraction peak.
a ¼ dhkl
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
h2 þ k2 þ l2
p
ð2Þ
where h, k and l are the Miller indices of the crystal planes
and dhkl is the separation of lattice planes. X-ray density
(Dx) was calculated using the following equation:
DX ¼ 8M
Na3
ð3Þ
where M is the molecular weight, N is the Avogadro’s
number, and a is the lattice constant. The surface mor-
phology was examined with a Field Emission-Scanning
Electron Microscopes, Nova Nano SEM 600 (FEI Co.,
Netherlands). Thermal decomposition behaviour of bare
and OA–PP123–NZFO MNPs was carried out in a tem-
perature range of 30–1000 C in argon atmosphere with a
heating rate of 10 C/min using STA 409 PC Luxx from
NETZSCH-Geratebau (Germany). The OA and PP123
coatings were investigated using Fourier Transform Infra-
red spectroscopy (ALPHA, Bruker) in the range of
400–4000 cm-1. The magnetic characterisations were
carried out with a Vibrating Scanning Magnetometer (Lake
Shore cryotronics-7400 series) under the applied field
of ± 20,000 G at room temperature. Zeta potential mea-
surements were performed using a zeta sizer (Nano Zs,
Nano series Malvern instruments). Measurements were
taken in water and in PBS. Zeta potential measurements
were done thrice for each sample at 30 electrode cycles.
3 Results and Discussion
3.1 OA–PP123 Coating of NZFO MNPs
PP123 were chosen for micellar encapsulation of NZFO
MNPs due to its biocompatibility and safety. PP123 are
approved by FDA for pharmaceutical and medical appli-
cations (Chiappetta and Sosnik 2007). PP123 is a water
soluble tri-block copolymer composed of a hydrophobic
central segment of poly (propylene oxide) [PPO] flanked
by two hydrophilic segments of poly(ethylene oxide)
[PEO]. Under the condition of over critical micelle con-
centration (CMC) in aqueous solution, amphiphilic block
copolymers can spontaneously form micelles to reduce free
energy which comes from hydrophobic interactions in
aqueous solution or physiological environment (Song et al.
2009). The individual block copolymer molecule can be
self-assembled into the micelles, and form core shell
structure, where the MNPs are located in the core and thus
can be effectively protected; have very low toxicity to
human body, a prolonged circulation time in the blood
owing to its evading scavenging ability by the macrophage
system and renal clearance owing to its hydrophilic
micelles shell (Song et al. 2009). First, the MNPs were
coated with OA, acting as an adhesive to provide affinity to
PP123 copolymer for its easy attachment to the MNP. As a
surfactant, OA also helps to reduce particle agglomeration
which may occur due to dipole–dipole interactions and
hydrophobic nature of NZFO. Figure 1 shows a schematic
representation of the coating of NZF sample with OA and
PP123.
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3.2 X-ray Diffraction
XRD was performed on the OA–PP123-coated NZFO
MNPs and the pattern is shown in Fig. 2. The effects of
OA–PP123 coating on the structural properties of NZFO
MNPs are presented in Table 1. Like the XRD of the bare
sample, the diffraction peaks have the characteristic peaks
of spinel cubic structure (JCPDS card no. 10-0325). This
clearly showed that the sample retained the spinel structure
even after coating by OA–PP123 but with a suppression of
diffraction peaks apparently due to the presence of OA–
PP123 coatings which affects the surface of MNPs and
induces internal strain due to lattice mismatch. There is a
pronounced change in the calculated structural properties
of the coated sample with the coated sample recording
higher values of all calculated structural properties than the
bare sample. The changes in the structural properties of
coated sample might be due to the OA–PP123 coating. The
calculated crystallite sizes (D) for bare and coated NZFO
MNPs are 55 and 53 nm, respectively (Table 1).
3.3 FTIR Spectra
The FTIR spectra of bare, OA-coated and OA–PP123-
coated NZFO MNPs are shown in Fig. 3. In case of the
bare sample, the band observed at 536 cm-1 corresponds to
stretching vibrations of Fe–O which is a typical metal–
oxygen absorption band for the spinel structure of the
ferrite. There is a shift of this absorption band to 537 cm-1
in the OA-coated sample and to 533 cm-1 in the OA–
PP123-coated sample confirming the presence of the ferrite
NPs in both nanocomposites. For the OA-coated sample
(Fig. 3b), the weak peak at 1255 cm-1 is due to C–O
stretching; and the peaks at 1453 and 1533 cm-1 are cor-
responding to the asymmetric and symmetric COO-
stretching modes, respectively. These two peaks are
attributed to the oleate ion immobilised on the MNPs
surface (Montagne et al. 2002). The band at 1709 cm-1 is
due to the stretching vibration of C=O in OA. The
absorption peaks at 2918 and 2851 cm-1 were attributed to
the asymmetric CH2 stretching and the symmetric CH2
Fig. 1 Scheme shwing the
coating of NZFO MNPs with
OA and PP123
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Fig. 2 X-ray diffraction
patterns of a bare and b OA–
PP123-coated NZFO MNPs
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stretching, respectively. For the OA–PP123-coated sample
(Fig. 3c), the peaks at 1100, 1243, 1373 and 1465 cm-1
correspond to the C–H stretching and deformation vibra-
tions of PP123 polymer. The absorption peaks at 2915 and
2852 cm-1 were attributed to the asymmetric CH2
stretching and the symmetric CH2 stretching, respectively,
as present in PEO. The result of the significant shift of the
ferrite peak in the OA–PP123-coated sample to a lower
frequency indicated that the hydrocarbon chains in the
monolayer surrounding the nanoparticles were in a closed
packed crystalline state (Mahdavi et al. 2013). The FTIR
study confirms the attachment of OA–PP123 coatings on
the NZFO MNPs.
3.4 Morphological Analysis
The morphology of bare and OA–PP123 NZFO MNPs was
determined by FE-SEM. Figure 4 shows typical FE-SEM
images of bare and OA–PP123-coated NZFO MNPs. It can
be seen from Fig. 4 that there is an enlargement of NZFO
particles after OA–PP123 coating thereby negating the
results obtained from XRD. It is important to state that the
crystallite size is determined on the basis of XRD pattern of
nanoparticles whereas the particle size determined is the
overall size of the composite. Usually, the particle size
calculated from FE-SEM/TEM is higher than that of
crystallite size calculated from the XRD (Jadhav et al.
2015). Also, in the presence of a polymer, small particles
have tendency to join together and constitute large parti-
cles. Similar results have also been reported for polyani-
line/NiFe2O4 (Khairy 2014) and PEG/Mn1-xZnxFe2O4
(Kareem et al. 2015) nanocomposite systems. The bare
sample displays an irregular and agglomerated morphology
while the coated sample shows a more regular shape and
lesser agglomeration. Lesser agglomeration after coating
may be attributed to the presence of the non-magnetic
surface layer of OA–PP123 which readily decreases the
interparticle interaction of the MNPs.
3.5 Thermogravimetric Analysis
TG analysis of bare and OA–PP123-coated NZFO MNPs is
shown in Fig. 5. TGA for bare NZFO MNPs (Fig. 5a)
shows a little gain in weight (about 2%) which might be
Table 1 Effects of OA–PP123 coating on the structural properties of NZFO MNPs
Ni0.3Zn0.7Fe2O4 MNPs Crystallite size, D (nm) Lattice constant, a (nm) Unit cell volume, V (nm
3) X-ray density, Dx (g/cm
3)
Uncoated 55 0.833 0.578 5.495
OA–PP123 coated 53 0.838 0.588 –
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due to the generation of foam (combustion synthesis using
glycine–nitrate mixture results in very high voluminous
and foamy powder more so, when more than stoichiometric
amount of glycine was used in the synthesis of NZFO
MNPs) and contact with furnace wall (Widmann 2001).
The weight loss (* 28%) in the temperature range of
180–500 C which is not seen in the coated sample
(Fig. 5b) might be due to the complete decomposition of
carbonaceous matter resulting from the decomposition of
excess glycine fuel (decomposition is consistent with the
TGA of glycine). The procedure used for the coating of the
bare MNPs with OA–PP123 which involved several
washings in organic solvent and water coupled with the
heating carried out might have removed the excess glycine
seen in the bare sample. It can also be seen that in the
500–1000 C temperature range, no weight loss is
Fig. 4 FE-SEM images of NZFO MNPs. a Bare and b OA–PP123 coated
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Fig. 5 Thermogravimetric
curves of NZFO MNPs. a Bare
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observed confirming the presence of pure NZFO phase.
Therefore, the TG curve suggests that a pure NZFO phase
is present since there is no further weight loss seen in the
TG curve. For the OA–PP123-coated NZFO sample, two
major weight loss processes (consistent with the attached
molecules) are observed in the TG curve (Fig. 5b). Simi-
larly, two stage weight loss processes were observed in the
TG of OA–Pluronic F127-coated LSMO MNPs (Thorat
et al. 2014). The first weight loss (* 5%) in the temper-
ature range of 300–450 C is due to the decomposition of
the attached PP123 co-polymer layer from the surface. The
second weight loss (* 8%) in the temperature range of
450–750 C is due to the decomposition of the covalently
bonded OA molecules to the MNPs’ surfaces. Similarly,
OA molecules decomposed in the temperature range of
450–600 C in the TG analysis of OA-capped perovskite
lead titanate (Wang et al. 2010). Thus, the TGA study
suggests the OA–PP123 coating on the surface of NZFO
MNPs.
3.6 Magnetic Properties
The hysteresis loops measured at room temperature for the
bare and OA–PP123-coated NZFO MNPs are shown in
Fig. 6. The saturation magnetization (Ms), remanent mag-
netization (Mr), coercivity (Hc) and squareness loop (Mr/
Ms) of the bare and coated sample are summarized in
Table 2. It can be seen that these values are higher in the
coated sample compared to the bare sample. The Ms value
of the coated sample (35 emu/g) is higher than the bare
sample (32 emu/g) at an applied field of ± 20,000 G at
300 K. Higher Ms values have also been reported for poly
vinyl alcohol (PVA)-coated Ni0.3Zn0.7Fe2O4 MNPs
(Rahimi et al. 2013) and Gd-substituted NiCa ferrite/PVA
nanocomposite (Prasad and Dolia 2012) systems. The
increase in magnetization of the coated sample is probably
due to the nanoparticles’ crystal growth after polymer
coating and spin injection or anti-spin canting being tran-
spired at the surfaces of the MNPs due to the interaction
with polymer chain (Prasad and Dolia 2012). Depending on
the applications, certain properties of MNP are desired. In
most biomedical applications, nanoparticles with higher
saturation magnetization are preferred because they pro-
vide higher sensitivity and efficiency (Colombo et al.
2012). The coated sample had a higher Mr, Hc and Mr/Ms
values than the bare sample. Ms and Hc are important
magnetic properties critical to biomedical applications. The
tuning of Ms to higher values is very important in
biosensing and drug delivery applications (Koh and
Josephson 2009; Gazeau et al. 2008) while increased Hc is
very important in hyperthermia (Kolhatkar et al. 2013).
The results show that OA–PP123 coatings tuned the
magnetic properties of Ms and Hc for increased efficiency
in biomedical applications.
3.7 Colloidal Stability Study
The colloidal stability of the bare and OA–PP123-coated
NZFO sample was evaluated by the zeta potential mea-
surements. Zeta potential measurement is an important
parameter for evaluation of MNPs in biomedical applica-
tions at physiological pH. The zeta potential distribution of
bare and coated sample using distilled water as a dispersant
was 11.9 and - 10.35 mV, respectively. The results show
there was a flip of charge after OA–PP123 coating. This
might be as a result of the ionization of the hydroxyl end of
the poly (ethylene oxide) chain when dispersed in water
conferring a negative charge on the oxygen atom hence,
leading to a negative zeta potential value. The pH-depen-
dent zeta potentials of the coated sample is - 26.2 mV at
pH 7.4 (physiological pH) and - 5.86 mV at pH 5.0
(cancer cell endosomal pH). These pH dependent zeta
potential values of the OA–PP123-coated sample can be
explained by recalling that the negative charge comes from
the ionization of the hydroxyl groups. At pH 7.4, more
number of the hydroxyl end groups would be ionized
making it more negatively charged. At pH 5.0, the
hydroxyl ionization is lesser thus lowering the net negative
charge. The zeta potential value (- 26.2 mV) of the coated
sample at physiological pH implies that the OA–PP123/
NZFO composites could maintain their dispersion stability
in physiological environment and thus have great potential
to be used in hyperthermia as a heating mediator and as a
drug delivery vehicle. However, further experiments like
hemocompatibility assay, cytotoxicity tests and magneticFig. 6 Magnetic hysteresis curves of NZFO MNPs measured at room
temperature for a bare and b OA–PP123 coated
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hyperthermia measurements have to be carried out to test
their real therapeutic potentials.
4 Conclusion
This work typically focussed on the effect of OA–PP123
coating on the magneto-structural and colloidal stability
study of NZFO MNPs with their potential biomedical
applications in mind. The spinel NZFO MNPs have been
successfully prepared by the low temperature auto-com-
bustion method using a glycine fuel-rich composition
without any further heat treatment at high temperature. The
surfaces of the synthesised MNPs were functionalised with
OA–PP123 thereby conferring suitable chemical, physical
and physiological properties for biomedical applications.
XRD results showed the formation of cubic spinel crys-
talline phase with and without coating of OA–PP123. The
results of thermal and spectro-analysis indicated that there
was an interaction between OA–PP123 coatings and NZFO
MNPs. FE-SEM result shows that there was enlargement of
particle size after coating but revealed a more regular shape
and lesser agglomeration. After coating, the MNPs retained
the hysteresis loop of the ferrimagnetic nature at room
temperature under applied magnetic field. The values of Ms
and Hc increased with OA–PP123 coatings in the com-
posite. The high zeta potential value of the coated sample
at physiological pH is an important parameter for suc-
cessful application of the nanofluid biomedically. The
combination of magnetic properties and the stability of the
particles in physiological suspensions suggest that these
materials have potentials to be used in biomedical appli-
cations. Also, appreciable amount of drug can be loaded on
to the polymer shell serving as a drug delivery system.
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